Curative effects of hepatocyte growth factor in treatment of infant hepatitis syndrome caused by cytomega lovirus with ganciclovir
10.3760/cma.j.issn.1673-4408.2015.05.025
- VernacularTitle:促肝细胞生长素联合更昔洛韦治疗婴儿巨细胞病毒肝炎的疗效观察
- Author:
Xiaojun LI
;
Xiaolan LI
- Publication Type:Journal Article
- Keywords:
Hepatocyte growth factor;
Ganciclovir;
Cytomegalovirus;
Infant hepatitis syndrome
- From:
International Journal of Pediatrics
2015;42(5):575-577
- CountryChina
- Language:Chinese
-
Abstract:
Objective To compare the curative effect of hepatocyte growth factor(HGF) in treatment of infant hepatitis syndrome (IHS) caused by cytomegalovirus with ganciclovir.Methods Sixty-eight cases with infant hepatitis syndrome caused by cytomegalovirus from neonatology department of our hospital from September 2010 to September 2014 were randomly divided into two groups, the observation group (32 cases)took HGF and ganciclovir therapy and the control group (36 cases) only received ganciclovir treatment Both groups were given conventional guard liver therapy.After one month of treatment, liver function, cytomegalovirus DNA content,extinction time of jaundice, treatment efficiency and the adverse reaction rate were evaluated for two groups.Results Liver function of children in observation group improved significantly after treatment compared with the control group, CMV-DNA quantitatively lower than the control group, the extinction time of jaundice was earlier than the latter,and the overall treatment efficiency was higher in observation group (P ＜0.05);The adverse reaction has no significant difference between two groups (P ＞ 0.05).Conclusion HGF combined with ganciclovir treatment can significantly improve liver function in patients of IHS caused by cytomegalovirus infection, and can collaboratively reduce viral load.Symptoms subside quickly with fewer adverse reactions, which is worthy of clinical promotion.
